Siobhan O'BRien

Siobhan O'BRien

Auto-generated profile, based on publicly available information

Siobhan O'BRien

Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2023 in Cancer Research Communications
Verified
Journal Article
Open access
PDF file
SOSiobhan O'BRien
Siobhan O'BRien
TUTajinder Ubhi
Tajinder Ubhi
LWLucie Wolf
Lucie Wolf
KGKrishna Gandhi
Krishna Gandhi
SLSichun Lin
Sichun Lin
SAStephane Angers
Stephane Angers
FBXW7 is a commonly mutated tumor suppressor gene that functions to regulate numerous oncogenes involved in cell-cycle regulation. Genome-wide CRISPR fitness screens identified a signature of DNA repair and DNA damage response genes as required for the growth of FBXW7-knockout cells. Guided by these findings, we show that FBXW7-mutant cells have high levels of replication stress, which results in a genotype-specific vulnerability to inhibition of the ATR signaling pathway, as these mutant cells become heavily reliant on a robust S–G2 checkpoint. ATR inhibition induces an accelerated S-phase, leading to mitotic catastrophe and cell death caused by the high replication stress present in FBXW7−/− cells. In addition, we provide evidence in cell and organoid studies, and mining of publicly available high-throughput drug screening efforts, that this genotype-specific vulnerability extends to multiple types of cancer, providing a rational means of identifying responsive patients for targeted therapy. Significance: We have elucidated the synthetic lethal interactions between FBXW7 mutation and DNA damage response genes, and highlighted the potential of ATR inhibitors as targeted therapies for cancers harboring FBXW7 alterations.

3 February 2025
Verified
Dataset
Closed access
CSCandace Savonen
Candace Savonen
PPPhoebe C.R. Parrish
Phoebe C.R. Parrish
KIKathryn J. Isaac
Kathryn J. Isaac
DGDaniel Groso
Daniel Groso
MFMarissa Fujimoto
Marissa Fujimoto
ABAlice H. Berger
Alice H. Berger
Helps find meaningful patterns in complex genetic experiments. First gimap takes data from paired CRISPR (Clustered regularly interspaced short palindromic repeats) screens that has been pre-processed to counts table of paired gRNA (guide Ribonucleic Acid) reads. The input data will have cell counts for how well cells grow (or don't grow) when different genes or pairs of genes are disabled. The output of the 'gimap' package is genetic interaction scores which are the distance between the observed CRISPR score and the expected CRISPR score. The expected CRISPR scores are what we expect for the CRISPR values to be for two unrelated genes. The further away an observed CRISPR score is from its expected score the more we suspect genetic interaction. The work in this package is based off of original research from the Alice Berger lab at Fred Hutchinson Cancer Center (2021) .

29 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
SOSiobhan O’Brien
Siobhan O’Brien
MFMarissa H. Fujimoto
Marissa H. Fujimoto
ALAmy R. Lowe
Amy R. Lowe
ABAlice H. Berger
Alice H. Berger
Buffering among paralogous genes is a well-described phenomenon in which genetic redundancy provides genetic robustness. Shared function among paralogs allows for a compensation effect when one or more paralog family genes are inactivated. Considering the role of transcriptional adaptation in influencing gene expression among highly homologous genes, we sought to identify whether transcriptional adaptation has a role in paralog buffering. We performed Perturb-seq of 110 paralog gene knockouts and assessed compensatory gene expression effects among paralogs as well as at the whole transcriptome level. This analysis identified six paralog pairs that undergo a transcriptional adaptation following CRISPR-mediated loss of one paralog in the pair. Further, we found that the upregulation of TIA1 following paralog TIAL1 loss requires nonsense-mediated decay, and active nuclear import via the importin IPO8. These data provide a comprehensive evaluation of transcriptional adaptation and show that transcriptional adaptation is recurrent but not pervasive among paralogous human genes.

11 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JSJessica J. Simon
Jessica J. Simon
SPSriram Pendyala
Sriram Pendyala
AAA. Felicia Adebanjo
A. Felicia Adebanjo
DHDaniel L. Holmes
Daniel L. Holmes
MWMadeline Walsh
Madeline Walsh
DFDouglas M. Fowler
Douglas M. Fowler
Variation alters inherent protein properties like thermodynamic stability and catalytic activity, and these intrinsic effects are shaped by the cellular environment. The RAS–MAPK signaling pathway typifies this interplay, with hundreds of proteins acting in concert through regulated states and interactions to transduce signals. To explore how cell context influences variant effects, we measured the abundance and pathway activity of 186,676 variants across 17 MAPK proteins in human cells under diverse conditions, for a total of 503,099 measurements. We discovered 14,412 dominant negative variants, nearly all previously unknown, that disrupt specific domains or interaction interfaces while preserving other functions. MAPK dominant negatives occur at conserved positions and are depleted from the human population relative to other activity-altering variants, representing a distinct constraint on the human genome. Modulating chaperone activity exposed previously hidden effects of genetic variation on protein abundance in human cells, revealing the HSP90 dependence of 67% of missense variants across the pathway. Combining hundreds of experimental and predicted protein interaction structures with variant effect data distinguished functional from non-functional interaction interfaces and revealed how their disruption affected function. We resolved the overlapping KRAS-LZTR1-SOS1 interface into partner-specific and shared binding determinants, identified allosteric networks supporting each interaction, and uncovered distinct mechanisms by which variants promote LZTR1-mediated degradation. Thus, we measure variant effects at pathway scale in human cells, illuminating fundamental MAPK pathway signaling mechanisms and demonstrating that cellular context profoundly shapes the effect of most variants.

6 August 2026 in Journal of Open Source Software
Verified
Journal Article
Open access
PDF file
CSCandace Savonen
Candace Savonen
PPPhoebe C. R. Parrish
Phoebe C. R. Parrish
KIKathryn J. Isaac
Kathryn J. Isaac
DGDaniel Groso
Daniel Groso
MFMarissa Fujimoto
Marissa Fujimoto
ABAlice H. Berger
Alice H. Berger

3 October 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
TSTanja Sack
Tanja Sack
PDPiriththiv Dhavarasa
Piriththiv Dhavarasa
DSDaniel Szames
Daniel Szames
SOSiobhan O’brien
Siobhan O’brien
SAStephane Angers
Stephane Angers
SKShana O. Kelley
Shana O. Kelley
A major impediment to the characterization of mtDNA repair mechanisms, in comparison to nuclear DNA repair mechanisms, is the difficulty of specifically addressing mitochondrial damage. Using a mitochondria-penetrating peptide, we can deliver DNA-damaging agents directly to mitochondria, bypassing the nuclear compartment. Here, we describe the use of a mtDNA-damaging agent in tandem with CRISPR/Cas9 screening for the genome-wide discovery of factors essential for mtDNA damage response. Using mitochondria-targeted doxorubicin (mtDox) we generate mtDNA double-strand breaks (mtDSBs) specifically in this organelle. Combined with an untargeted Dox screen, we identify genes with significantly greater essentiality during mitochondrial versus nuclear DNA damage. We characterize the essentially of our top hit - WRNIP1 - observed here for the first time to respond to mtDNA damage. We further investigate the mitochondrial role of WRNIP1 in innate immune signaling and nuclear genome maintenance, outlining a model that experimentally supports mitochondrial turnover in response to mtDSBs.